Spot Trading’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
$54.7M Buy
675,500
+2,900
+0.4% +$222K 0.94% 4
2017
Q2
$47.6M Buy
672,600
+195,700
+41% +$13M 0.93% 3
2017
Q1
$32.4M Buy
476,900
+106,800
+29% +$7.51M 1.08% 4
2016
Q4
$26.5M Buy
370,100
+148,700
+67% +$11.1M 0.62% 4
2016
Q3
$17.5M Buy
221,400
+61,800
+39% +$5.02M 0.36% 22
2016
Q2
$13.3M Sell
159,600
-183,300
-53% -$16.3M 0.23% 64
2016
Q1
$31.5M Buy
342,900
+43,200
+14% +$3.9M 0.56% 6
2015
Q4
$30.3M Buy
299,700
+28,100
+10% +$2.92M 0.32% 35
2015
Q3
$26.7M Buy
271,600
+44,900
+20% +$4.99M 0.26% 51
2015
Q2
$26.5M Sell
226,700
-60,900
-21% -$6.65M 0.24% 47
2015
Q1
$28.2M Sell
287,600
-397,700
-58% -$40.4M 0.28% 38
2014
Q4
$64.6M Sell
685,300
-45,500
-6% -$4.71M 0.4% 18
2014
Q3
$77.8M Buy
730,800
+67,500
+10% +$6.61M 0.39% 19
2014
Q2
$55M Buy
663,300
+186,600
+39% +$14.5M 0.26% 39
2014
Q1
$33.8M Sell
476,700
-815,900
-63% -$64M 0.19% 80
2013
Q4
$97.1M Sell
1,292,600
-219,900
-15% -$15.3M 0.52% 14
2013
Q3
$95.1M Buy
1,512,500
+324,000
+27% +$19.4M 0.59% 8
2013
Q2
$60.9M Buy
+1,188,500
New +$61.9M 0.37% 20

Other funds holding GILD

Spot Trading's GILD Position: Q3 2017 in Review

Spot Trading increased its Gilead Sciences (GILD) stake by 101% in Q3 2017, buying an estimated $15.5M and bringing the position to 401,976 shares worth $32.6M. The position accounts for 0.56% of the portfolio, ranked #9.

Spot Trading first reported a position in GILD in Q2 2013 and has held it in 17 quarters since. 1,503 funds tracked by Wall St. Rank hold GILD as of Q3 2017.

  • Spot Trading held 401,976 shares of Gilead Sciences worth $32.6M as of Q3 2017.
  • Spot Trading bought 202,237 Gilead Sciences shares in Q3 2017, an estimated $15.5M.
  • Gilead Sciences made up 0.56% of Spot Trading's portfolio in Q3 2017, its #9 holding.
  • Spot Trading first reported a position in Gilead Sciences in Q2 2013 and has held it in 17 quarters since.
  • 1,503 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2017.

Based on Spot Trading's 13F filing for Q3 2017, filed 6 Nov 2017.